Jürgen Sandow

1.4k total citations
24 papers, 1.0k citations indexed

About

Jürgen Sandow is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Obstetrics and Gynecology. According to data from OpenAlex, Jürgen Sandow has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Obstetrics and Gynecology. Recurrent topics in Jürgen Sandow's work include Ovarian function and disorders (9 papers), Endometriosis Research and Treatment (7 papers) and Hypothalamic control of reproductive hormones (5 papers). Jürgen Sandow is often cited by papers focused on Ovarian function and disorders (9 papers), Endometriosis Research and Treatment (7 papers) and Hypothalamic control of reproductive hormones (5 papers). Jürgen Sandow collaborates with scholars based in Germany, United States and Canada. Jürgen Sandow's co-authors include Bernward A. Schölkens, Hannes Vogel, Wolfgang H. Vogel, W. von Rechenberg, Hamish M. Fraser, Herbert Kühl, Valérie B. Schini‐Kerth, Olaf Herkert, Rudi Busse and Jacques Donnez and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Jürgen Sandow

23 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Sandow Germany 15 334 208 207 158 117 24 1.0k
Scott G. Lundeen United States 23 130 0.4× 384 1.8× 354 1.7× 48 0.3× 460 3.9× 47 1.4k
Ainaz Mihanfar Iran 24 155 0.5× 824 4.0× 52 0.3× 36 0.2× 56 0.5× 45 1.5k
Özlem Bingöl Özakpınar Türkiye 18 75 0.2× 191 0.9× 47 0.2× 49 0.3× 21 0.2× 74 1.0k
Maie Al‐Bader Kuwait 16 181 0.5× 290 1.4× 77 0.4× 72 0.5× 154 1.3× 41 797
Ilaria Paterni Italy 9 59 0.2× 360 1.7× 81 0.4× 21 0.1× 282 2.4× 9 870
Murugesan Palaniappan United States 19 218 0.7× 338 1.6× 148 0.7× 9 0.1× 77 0.7× 39 1.1k
Frank Eisenberg United States 21 53 0.2× 484 2.3× 171 0.8× 5 0.0× 71 0.6× 42 1.4k
Ayako Harada Japan 17 32 0.1× 647 3.1× 400 1.9× 22 0.1× 228 1.9× 32 1.3k
Yue Jiang China 26 433 1.3× 886 4.3× 109 0.5× 258 1.6× 146 1.2× 86 2.0k
Charles Huggins United States 8 34 0.1× 358 1.7× 125 0.6× 9 0.1× 303 2.6× 11 1.0k

Countries citing papers authored by Jürgen Sandow

Since Specialization
Citations

This map shows the geographic impact of Jürgen Sandow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Sandow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Sandow more than expected).

Fields of papers citing papers by Jürgen Sandow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Sandow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Sandow. The network helps show where Jürgen Sandow may publish in the future.

Co-authorship network of co-authors of Jürgen Sandow

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Sandow. A scholar is included among the top collaborators of Jürgen Sandow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Sandow. Jürgen Sandow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varenhorst, Eberhard, et al.. (2006). Duration of Testosterone Suppression after a 9.45mg Implant of the GnRH-Analogue Buserelin in Patients with Localised Carcinoma of the Prostate. European Urology. 50(3). 483–489. 16 indexed citations
2.
Schmidt, Carsten, et al.. (2003). In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis. Journal of Controlled Release. 94(1). 25–37. 79 indexed citations
3.
Daschner, Markus, Bärbel Philippin, Rudolf J. Wiesner, et al.. (2002). Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney International. 62(5). 1582–1590. 8 indexed citations
4.
Vogel, Hannes, Wolfgang H. Vogel, Bernward A. Schölkens, & Jürgen Sandow. (2002). Drug Discovery and Evaluation. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 272 indexed citations
5.
Herkert, Olaf, Herbert Kühl, Jürgen Sandow, Rudi Busse, & Valérie B. Schini‐Kerth. (2001). Sex Steroids Used in Hormonal Treatment Increase Vascular Procoagulant Activity by Inducing Thrombin Receptor (PAR-1) Expression. Circulation. 104(23). 2826–2831. 93 indexed citations
6.
7.
Michael, Katja, Valentin Wittmann, Wolfgang König, Jürgen Sandow, & Horst Kessler. (1996). S‐ and C‐glycopeptide derivatives of an LH‐RH agonist. International journal of peptide & protein research. 48(1). 59–70. 25 indexed citations
8.
Geel, Bert van, et al.. (1991). The relation between pharmacokinetics and endocrine effects of buserelin implants in patients with mastalgia. Clinical Endocrinology. 34(4). 253–258. 9 indexed citations
9.
Fraser, Hamish M., et al.. (1990). Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis. Fertility and Sterility. 53(1). 61–68. 15 indexed citations
10.
Donnez, Jacques, et al.. (1989). Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography. Fertility and Sterility. 51(6). 947–950. 78 indexed citations
11.
Donnez, Jacques, et al.. (1989). Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis. Fertility and Sterility. 52(1). 27–30. 50 indexed citations
12.
Kiesel, Ludwig, et al.. (1989). Serum Concentration and Urinary Excretion of the Luteinizing Hormone-Releasing Hormone Agonist Buserelin in Patients with Endometriosis. The Journal of Clinical Endocrinology & Metabolism. 68(6). 1167–1173. 14 indexed citations
13.
Sandow, Jürgen, et al.. (1988). Investigations upon the mechanism of inhibition of spermatogenesis in the rat by a dimeric ethynodiol-testosterone ester. European Journal of Endocrinology. 117(4). 536–544. 2 indexed citations
14.
Lemay, André, et al.. (1988). Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist. Fertility and Sterility. 49(5). 802–808. 4 indexed citations
15.
16.
Horsthemke, Bernhard, et al.. (1981). Degradation of luteinizing hormone — Releasing hormone and analogs by adenohypophyseal peptidases. Biochemical and Biophysical Research Communications. 100(2). 753–759. 46 indexed citations
17.
Happ, J., et al.. (1978). Treatment of Cryptorchidism with Pernasal Gonadotropin-Releasing Hormone Therapy. Fertility and Sterility. 29(5). 546–551. 26 indexed citations
18.
Sandow, Jürgen, et al.. (1978). Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing Hormone. Fertility and Sterility. 30(2). 205–209. 108 indexed citations
19.
Geiger, Rolf & Jürgen Sandow. (1977). Synthetische Analoga des Corticotropins; Beitrag von 5‐Glutaminsäure oder 5‐Glutamin zur biologischen Wirkung. Justus Liebig s Annalen der Chemie. 1977(6). 897–903.
20.
Geiger, Rolf, et al.. (1974). [8-Homoarginin](Lutenisierendes Hormon freisetzendes Hormon). Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 355(2). 1526–1534. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott G. Lundeen Breakdown of academic impact, for papers by Ainaz Mihanfar Breakdown of academic impact, for papers by Özlem Bingöl Özakpınar Breakdown of academic impact, for papers by Maie Al‐Bader Breakdown of academic impact, for papers by Ilaria Paterni Breakdown of academic impact, for papers by Murugesan Palaniappan Breakdown of academic impact, for papers by Frank Eisenberg Breakdown of academic impact, for papers by Ayako Harada Breakdown of academic impact, for papers by Yue Jiang Breakdown of academic impact, for papers by Charles Huggins
Rankless by CCL
2026